Infertility  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT01851512: A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Completed
1
27
RoW
T-R (Test-Reference drug), Drug: DA-3803 (Test drug), Drug: Ovidrel liquid injection (Referecne drug), R-T (Reference-Test drug)
Dong-A Pharmaceutical Co., Ltd.
Infertility, Induction of Ovulation
08/10
04/11
NCT06599528: A Comparing Study Between SJ04 and OvidrelĀ® in Healthy Subjects

Not yet recruiting
1
48
RoW
T-R (Test-Reference drug), R-T (Reference-Test drug)
Suzhou Centergene Pharmaceuticals Co.,Ltd.
Assisted Reproductive Technology, Female Infertility
06/26
12/26

Download Options